The rise of GLP-1 weight loss medications has sparked an intriguing trend in the world of plastic surgery, particularly on Long Island. These medications, such as Ozempic, Wegovy, and Zepbound, have become a popular tool in the battle against obesity, but their rapid and dramatic effects on the body have led to a unique set of challenges and opportunities.
Personally, I find it fascinating how these drugs, originally intended for diabetes treatment, have transformed the obesity landscape. With their ability to slow digestion and prolong feelings of fullness, they've become a game-changer for many. However, as Jeanne Erland's story illustrates, the journey doesn't end with weight loss.
One of the most striking side effects is the 'Ozempic face,' a term that describes the gaunt and jowly appearance some patients develop due to rapid volume loss in the face. But it's not just the face that's affected. Excess skin can hang from the abdomen, breasts, thighs, and arms, creating both aesthetic and functional issues.
Dr. Kevin Kresofsky, a plastic surgeon, describes it as a balloon deflating, where the skin loses its ability to recoil and tighten. This has led to a surge in patients seeking plastic surgery, with about 20% of those taking GLP-1 medications for weight loss undergoing procedures, and a further 39% considering it.
The impact is particularly notable for female patients who have experienced weight fluctuations due to pregnancy. Their bodies, having gone through significant changes, often struggle to bounce back, with the belly being a common area of concern for both aesthetics and functionality.
What many people don't realize is the impact of weight loss on a person's center of gravity. The overhanging skin can cause strain on the shoulders and back, and rapid weight loss can also lead to muscle wasting and loss of core strength.
Dr. David Pincus, another plastic surgeon, notes that he's seeing a lot of weight loss even in patients who were already skinny, and this is leading to a range of skin issues from the face down to the knees. For patients with sagging breasts, the result can be neck and back pain, often requiring a breast lift or augmentation.
The implications of these medications go beyond aesthetics. Body contouring surgery after massive weight loss is often considered reconstructive rather than cosmetic, and procedures deemed medically necessary may be covered by insurance. For instance, a panniculectomy, which removes hanging skin from the lower abdomen, is one such procedure.
However, there are precautions to be taken. Patients on GLP-1 medications need to stop taking them for two to three weeks before undergoing procedures that use anesthesia due to potential complications.
In my opinion, the key to a successful and healthy weight loss journey with these medications lies in combining them with good nutrition and exercise. As Dr. David Pechman, director of bariatric surgery, points out, resistance training and adequate protein intake are crucial to maintaining muscle content and elasticity.
Jeanne Erland's story is a testament to this. She not only took Zepbound but also underwent counseling to address the reasons for her weight gain and worked with a physical therapist to exercise correctly. Her journey is a reminder that while GLP-1 medications can be a powerful tool, they are most effective when used as part of a holistic approach to health and wellness.
This trend raises important questions about the role of plastic surgery in obesity treatment and the evolving nature of beauty standards and body image. It's a complex issue with medical, psychological, and cultural implications, and it will be interesting to see how it develops in the future.
